Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial... per Li, G, Cappuccini, F, Marchevsky, NG, Aley, PK, Aley, R, Anslow, R, Bibi, S, Cathie, K, Clutterbuck, E, Faust, SN, Feng, S, Heath, PT, Kerridge, S, Lelliott, A, Mujadidi, Y, Ng, KF, Rhead, S, Roberts, H, Robinson, H, Roderick, MR, Singh, N, Smith, D, Snape, MD, Song, R, Tang, K, Yao, A, Liu, X, Lambe, T, Pollard, AJ

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents per Ratcliffe, H, Tiley, K, Longet, S, Tonry, C, Roarty, C, Watson, C, Amirthalingam, G, Vichos, I, Morey, E, Douglas, NL, Marinou, S, Plested, E, Aley, PK, Galiza, E, Faust, SN, Hughes, S, Murray, C, Roderick, MR, Shackley, F, Oddie, S, Lee, TWR, Turner, DPJ, Raman, M, Owens, S, Turner, PJ, Cockerill, H, Lopez Bernal, J, Ijaz, S, Poh, J, Shute, J, Linley, E, Borrow, R, Hoschler, K, Brown, KE, Carroll, MW, Klenerman, P, Dunachie, SJ, Ramsay, M, Voysey, M, Waterfield, T, Snape, MD